High mobility group box-1 is phosphorylated by protein kinase C zeta and secreted in colon cancer cells

Biochemical and Biophysical Research Communications

Volumn 424, Issue 2, 2012, Pages 321-326

  Lee, Hanna ^a   Park, Minhee ^a   Shin, Nara ^a   Kim, Gamin ^a   Kim, Yun Gi ^b   Shin, Jeon Soo ^a   Kim, Hoguen ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Colorectal carcinoma; HMGB1; Phosphorylation; Protein kinase C zeta

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; PROTEIN KINASE C IOTA; PROTEIN KINASE C LAMBDA; PROTEIN KINASE C ZETA; SMALL INTERFERING RNA;

ARTICLE; COLON CANCER; COLORECTAL CARCINOMA; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ACTIVE TRANSPORT, CELL NUCLEUS; COLONIC NEOPLASMS; HCT116 CELLS; HMGB1 PROTEIN; HUMANS; NUCLEAR LOCALIZATION SIGNALS; PHOSPHORYLATION; PROTEIN KINASE C; SERINE;

EID: 84864323582     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.06.116     Document Type: Article

References (29)

1. Goodwin G.H., Sanders C., Johns E.W. A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur. J. Biochem. 1973, 38:14-19.
2. Bustin M. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol. Cell. Biol. 1999, 19:5237-5246.
3. Weir H.M., Kraulis P.J., Hill C.S., Raine A.R., Laue E.D., Thomas J.O. Structure of the HMG box motif in the B-domain of HMG1. EMBO J. 1993, 12:1311-1319.
4. Youn J.H., Shin J.S. Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J. Immunol. 2006, 177:7889-7897.
5. Bonaldi T., Talamo F., Scaffidi P., Ferrera D., Porto A., Bachi A., Rubartelli A., Agresti A., Bianchi M.E. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 2003, 22:5551-5560.
6. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., Frazier A., Yang H., Ivanova S., Borovikova L., Manogue K.R., Faist E., Abraham E., Andersson J., Andersson U., Molina P.E., Abumrad N.N., Sama A., Tracey K.J. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
7. Abraham E., Arcaroli J., Carmody A., Wang H., Tracey K.J. HMG-1 as a mediator of acute lung inflammation. J. Immunol. 2000, 165:2950-2954.
8. Scaffidi P., Misteli T., Bianchi M.E. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002, 418:191-195.
9. Gardella S., Andrei C., Ferrera D., Lotti L.V., Torrisi M.R., Bianchi M.E., Rubartelli A. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 2002, 3:995-1001.
10. Baldassarre G., Battista S., Belletti B., Thakur S., Pentimalli F., Trapasso F., Fedele M., Pierantoni G., Croce C.M., Fusco A. Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma. Mol. Cell. Biol. 2003, 23:2225-2238.
11. Maroso M., Balosso S., Ravizza T., Liu J., Aronica E., Iyer A.M., Rossetti C., Molteni M., Casalgrandi M., Manfredi A.A., Bianchi M.E., Vezzani A. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat. Med. 2010, 16:413-419.
12. Thanos D., Maniatis T. The high mobility group protein HMG I(Y) is required for NF-kappa B-dependent virus induction of the human IFN-beta gene. Cell 1992, 71:777-789.
13. Kang H.J., Lee H., Choi H.J., Youn J.H., Shin J.S., Ahn Y.H., Yoo J.S., Paik Y.K., Kim H. Non-histone nuclear factor HMGB1 is phosphorylated and secreted in colon cancers. Lab Invest. 2009, 89:948-959.
14. Shirai Y., Saito N. Activation mechanisms of protein kinase C: maturation, catalytic activation, and targeting. J. Biochem. 2002, 132:663-668.
15. Lee H., Shin N., Song M., Kang U.B., Yeom J., Lee C., Ahn Y.H., Yoo J.S., Paik Y.K., Kim H. Analysis of nuclear high mobility group box 1 (HMGB1)-binding proteins in colon cancer cells: clustering with proteins involved in secretion and extranuclear function. J. Proteome Res. 2010, 9:4661-4670.
16. Davidson L.A., Aymond C.M., Jiang Y.H., Turner N.D., Lupton J.R., Chapkin R.S. Non-invasive detection of fecal protein kinase C betaII and zeta messenger RNA: putative biomarkers for colon cancer. Carcinogenesis 1998, 19:253-257.
17. Luna-Ulloa L.B., Hernandez-Maqueda J.G., Santoyo-Ramos P., Castaneda-Patlan M.C., Robles-Flores M. Protein kinase C zeta is a positive modulator of canonical Wnt signaling pathway in tumoral colon cell lines. Carcinogenesis 2011, 32:1615-1624.
18. Ito N., DeMarco R.A., Mailliard R.B., Han J., Rabinowich H., Kalinski P., Stolz D.B., Zeh H.J., Lotze M.T. Cytolytic cells induce HMGB1 release from melanoma cell lines. J. Leukoc. Biol. 2007, 81:75-83.
19. Levy M.F., Pocsidio J., Guillem J.G., Forde K., LoGerfo P., Weinstein I.B. Decreased levels of protein kinase C enzyme activity and protein kinase C mRNA in primary colon tumors. Dis. Colon Rectum 1993, 36:913-921.
20. Carneiro V.C., de Moraes Maciel R., de Abreu da Silva I.C., da Costa R.F., Paiva C.N., Bozza M.T., Fantappie M.R. The extracellular release of Schistosoma mansoni HMGB1 nuclear protein is mediated by acetylation. Biochem. Biophys. Res. Commun. 2009, 390:1245-1249.
21. de Abreu da Silva I.C., Carneiro V.C., Maciel Rde M., da Costa R.F., Furtado D.R., de Oliveira F.M., da Silva-Neto M.A., Rumjanek F.D., Fantappie M.R. CK2 phosphorylation of Schistosoma mansoni HMGB1 protein regulates its cellular traffic and secretion but not its DNA transactions. PLoS One 2011, 6:e23572.
22. Ito I., Fukazawa J., Yoshida M. Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils. J. Biol. Chem. 2007, 282:16336-16344.
23. Wisniewski J.R., Schulze E., Sapetto B. DNA binding and nuclear translocation of insect high-mobility-group- protein-1 (HMG1) proteins are inhibited by phosphorylation. Eur. J. Biochem. 1994, 225:687-693.
24. Zhang X., Wheeler D., Tang Y., Guo L., Shapiro R.A., Ribar T.J., Means A.R., Billiar T.R., Angus D.C., Rosengart M.R. Calcium/calmodulin-dependent protein kinase (CaMK) IV mediates nucleocytoplasmic shuttling and release of HMGB1 during lipopolysaccharide stimulation of macrophages. J. Immunol. 2008, 181:5015-5023.
25. Ali A.S., Ali S., El-Rayes B.F., Philip P.A., Sarkar F.H. Exploitation of protein kinase C: a useful target for cancer therapy. Cancer Treat. Rev. 2009, 35:1-8.
26. Liu Y., Wang B., Wang J., Wan W., Sun R., Zhao Y., Zhang N. Down-regulation of PKCzeta expression inhibits chemotaxis signal transduction in human lung cancer cells. Lung Cancer 2009, 63:210-218.
27. Wu J., Zhang B., Wu M., Li H., Niu R., Ying G., Zhang N. Screening of a PKC zeta-specific kinase inhibitor PKCzI257.3 which inhibits EGF-induced breast cancer cell chemotaxis. Invest. New Drugs 2010, 28:268-275.
28. Guo H., Gu F., Li W., Zhang B., Niu R., Fu L., Zhang N., Ma Y. Reduction of protein kinase C zeta inhibits migration and invasion of human glioblastoma cells. J. Neurochem. 2009, 109:203-213.
29. Ellerman J.E., Brown C.K., de Vera M., Zeh H.J., Billiar T., Rubartelli A., Lotze M.T. Masquerader: high mobility group box-1 and cancer. Clin. Cancer Res. 2007, 13:2836-2848.